GGrantIndex
Sort

141,003 grants matching cytokine

Dengue-Zika: Correlates of Cross-Protection in Non-Human Primates

$714,650
Carlos A Sariol · University Of Puerto Rico Med Sciences · R01 · FY2020 · AI

Natural Killer cells and the Immunogenetics of COVID-19

$714,601
Paul John Norman · University Of Colorado Denver · R01 · FY2023 · AI

Fusion: Vaccine conjugate technology to advance vaccine safety and efficacy

$714,601
David Jay Burkhart · University Of Montana · R01 · FY2019 · AI

Molecular Mechanisms of Growth Factor Modulated Proliferation

$714,590
William Farrar · Basic Sciences · Z01 · FY2007 · CA

Self-Regulation and Brain and Cognitive Health in Older Adults

$714,590
Suzanne C Segerstrom · University Of Kentucky · R01 · FY2019 · AG

The roles of Lyme spirochete adhesins in hematogenous dissemination

$714,563
Jenifer L Coburn · Medical College Of Wisconsin · R01 · FY2025 · AI

The roles of Lyme spirochete adhesins in hematogenous dissemination

$714,563
Jenifer L Coburn · Medical College Of Wisconsin · R01 · FY2024 · AI

The roles of Lyme spirochete adhesins in hematogenous dissemination

$714,563
Jenifer L Coburn · Medical College Of Wisconsin · R01 · FY2023 · AI

Assessing the root causes of chronic inflammation in HIV-infected individuals using drugs of abuse

$714,549
Warner C Greene · J. David Gladstone Institutes · R01 · FY2020 · DA

Assessing the root causes of chronic inflammation in HIV-infected individuals using drugs of abuse

$714,549
Melanie Maria Ott · J. David Gladstone Institutes · R01 · FY2021 · DA

Assessing the root causes of chronic inflammation in HIV-infected individuals using drugs of abuse

$714,549
Warner C Greene · J. David Gladstone Institutes · R01 · FY2019 · DA

Assessing the root causes of chronic inflammation in HIV-infected individuals using drugs of abuse

$714,549
Warner C Greene · J. David Gladstone Institutes · R01 · FY2017 · DA

(-)-Phenserine inhibition of neuronal death in Alzheimer’s disease and developing brain-labeled plasma exosomes assays as biomarkers for a phenserine phase 1b ascending dose trial

$714,437
Lon S Schneider · University Of Southern California · R01 · FY2023 · AG

Role of CLCA1 as a MIF decoy inhibitor in abdominal aortic aneurysms

$714,415
Peter Libby · Brigham And Women'S Hospital · R01 · FY2025 · HL

Rejuvenation of the T-cell compartment in aging primates

$714,414
Louis J. Picker · Oregon Health & Science University · R01 · FY2011 · AI

Nutritional and Biochemical/Genetic Markers of Cancer

$714,410
Jing Ma · Brigham And Women'S Hospital · R01 · FY2007 · CA

The development of a recombinant vaccine against human onchocerciasis

$714,313
Sara Lustigman · New York Blood Center · R01 · FY2010 · AI

The Functional Significance of CTL Escape

$714,288
David I Watkins · University Of Miami School Of Medicine · R37 · FY2016 · AI

GENETIC, IMMUNOLOGIC AND MECHANISTIC BASIS OF HUMAN NK CELL DEFICIENCY

$714,198
Jordan Scott Orange · Columbia University Health Sciences · R01 · FY2020 · AI

Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors

$714,132
Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · CA

T Cell Differentiation and Repertoire Selection

$714,129
Alfred Singer · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Novel Targets for Vaccine Therapy

$714,123
Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

CD40 monocyte in chronic kidney disease

$714,044
Hong Wang · Temple Univ Of The Commonwealth · R01 · FY2020 · DK

Defining Ocular Monkey Pox Pathogenic Mechanisms

$713,991
Vaithilingaraja Arumugaswami · University Of California Los Angeles · R01 · FY2025 · EY

Reducing Depressive Symptoms in Physically Ill Youth

$713,974
Eva M Szigethy · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · MH